Psychedelics in Psychiatry: Promise vs. Proof

Send us questions here!

Are psychedelics the future of psychiatry—or just another wave of hype? In this episode, Maria and Tabitha sit down with John Greeley to break down what the research really says about psychedelics like psilocybin, MDMA, and ketamine. We cover safety, harm reduction, cultural concerns, and what clinicians and patients alike need to know.

✨ Learn about:

• The science behind psychedelics and the brain
• Why harm reduction matters
• How providers can support patients using psychedelics
• The cultural and ethical tensions shaping this field

🔔 Subscribe for more honest, neurodivergent-affirming conversations on mental health.

 📖 Learn more: paperflowerpsychiatry.com

Socials:
Facebook: Paperflower Psychiatry
Instagram&Threads: @paperflowerpsychiatry
Tiktok: @dr.mariaingalla
Websites:
www.paperflowerpsychiatry.com
www.paperflowerinstitute.com
www.courses.paperflowerinstitute.com